Dr. Jeremy Brownstein, MD

Dr. Brownstein practices at OSU Radiation Oncology in Columbus, Ohio.

Dr. Brownstein's NPI, 1134565120, was assigned on May 16, 2013. Dr. Brownstein graduated from Renaissance School of Medicine at Stony Brook University in 2013. Dr. Brownstein holds Ohio license 35136284.

Dr. Brownstein's primary practice is OSU Radiation Oncology, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-8415.

Dr. Brownstein's primary practice is OSU Radiation Oncology in Columbus, Ohio. Dr. Brownstein is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Brownstein to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brownstein practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Brownstein's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Brownstein is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Brownstein's licenses on file in 3 states: Ohio, Massachusetts and North Carolina.

Dmand AI lists bone cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Brownstein treats.

CMS data shows 1,457 Medicare services from Dr. Brownstein across 12 procedure codes in 2024, for 175 Medicare patients. Medicare paid $114,202 for them.

CMS counts 175 Medicare patients who saw Dr. Brownstein in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brownstein's median patient age at 70, with 44% women.

In 2024, Dr. Brownstein wrote 33 Medicare Part D claims for 25 patients. 94% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $218 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Brownstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brownstein as offering telehealth.

Dmand AI links 14 papers to Dr. Brownstein, published from 2020 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Dose Fractionation, Radiation. Dr. Brownstein has published most often in Int J Radiat Oncol Biol Phys. Dr. Brownstein's most frequent co-authors are Karl Erick Haglund, MD, PhD, Terence Williams, MD and David Paul Carbone, MD, PhD.

Dmand AI links Dr. Brownstein to 2 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Carcinoma, Bronchogenic. Ohio State University Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 5 general payments to Dr. Brownstein from 4 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,946.

Dr. Brownstein graduated from Renaissance School of Medicine at Stony Brook University in 2013.

Dr. Brownstein is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.